Details for New Drug Application (NDA): 202292
✉ Email this page to a colleague
The generic ingredient in MYTESI is crofelemer. One supplier is listed for this compound. Additional details are available on the crofelemer profile page.
Summary for 202292
Tradename: | MYTESI |
Applicant: | Napo Pharms Inc |
Ingredient: | crofelemer |
Patents: | 2 |
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for 202292
Generic Entry Date for 202292*:
Constraining patent/regulatory exclusivity:
Dosage:
TABLET, DELAYED RELEASE;ORAL |
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Pharmacology for NDA: 202292
Suppliers and Packaging for NDA: 202292
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
MYTESI | crofelemer | TABLET, DELAYED RELEASE;ORAL | 202292 | NDA | Napo Pharmaceuticals, Inc. | 70564-802 | 70564-802-60 | 60 TABLET, COATED in 1 BOTTLE (70564-802-60) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, DELAYED RELEASE;ORAL | Strength | 125MG | ||||
Approval Date: | Dec 31, 2012 | TE: | RLD: | Yes | |||||
Patent: | ⤷ Sign Up | Patent Expiration: | Oct 31, 2031 | Product Flag? | Substance Flag? | Delist Request? | |||
Patented Use: | SYMPTOMATIC RELIEF OF NON-INFECTIOUS DIARRHEA | ||||||||
Patent: | ⤷ Sign Up | Patent Expiration: | Oct 31, 2031 | Product Flag? | Substance Flag? | Delist Request? | |||
Patented Use: | SYMPTOMATIC RELIEF OF NON-INFECTIOUS DIARRHEA |
Expired US Patents for NDA 202292
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Napo Pharms Inc | MYTESI | crofelemer | TABLET, DELAYED RELEASE;ORAL | 202292-001 | Dec 31, 2012 | ⤷ Sign Up | ⤷ Sign Up |
Napo Pharms Inc | MYTESI | crofelemer | TABLET, DELAYED RELEASE;ORAL | 202292-001 | Dec 31, 2012 | ⤷ Sign Up | ⤷ Sign Up |
Napo Pharms Inc | MYTESI | crofelemer | TABLET, DELAYED RELEASE;ORAL | 202292-001 | Dec 31, 2012 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription